About Deafness with labyrinthine aplasia, microtia, and microdontia
Deafness with labyrinthine aplasia, microtia, and microdontia is a rare disease catalogued by Orphanet (ORPHA:90024). It is associated with the FGF3 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Deafness with labyrinthine aplasia, microtia, and microdontia trials.
Search ClinicalTrials.gov for "Deafness with labyrinthine aplasia, microtia, and microdontia" or filter by Orphanet code ORPHA:90024 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Deafness with labyrinthine aplasia, microtia, and microdontia trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Deafness with labyrinthine aplasia, microtia, and microdontia. Updated daily.